Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage—Similarities and Differences with the Myeloid Lineage and Specific VulnerabilitiesLukasz Komorowski, Małgorzata Firczuk, Klaudyna Fidyt et al.|International Journal of Molecular Sciences|2020Cited by 36
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Małgorzata Firczuk, Krzysztof Domka et al.|Oncogene|2022Cited by 18
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitorsLukasz Komorowski, Małgorzata Firczuk, Agnieszka Dąbkowska et al.|HemaSphere|2024Cited by 3
PF161 THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVOKlaudyna Fidyt, Małgorzata Firczuk, Agata Pastorczak et al.|HemaSphere|2019Cited by 0
Pharmacological Induction of NOXA Sensitizes High-Risk B Cell Acute Lymphoblastic Leukemia Cells to VenetoclaxKlaudyna Fidyt, Małgorzata Firczuk, Julia Cyran et al.|Blood|2020Cited by 0